Better standards needed for industry sponsored clinical trials

BMJ 2002; 325 doi: (Published 02 November 2002) Cite this as: BMJ 2002;325:985
  1. Janice Hopkins Tanne
  1. New York

    Three papers in the New England Journal of Medicine highlight problems of academic freedom and scientific integrity in agreements between medical schools and industry sponsors who pay for many clinical trials.

    Agreements between industry and medical schools fall far short of the guidelines of the International Committee of Journal Editors and the Association of American …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription